Proliferative vitreoretinopathy
<p><strong>Background:</strong> Proliferative vitreoretinopathy (PVR) is a disease characterized by formation of membranes on both surfaces of the retina and vitreous base. PVR is a wound healing response which is inadequate and uncontrolled in the eye. Identifying the risk factors...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Medical Association
2005-10-01
|
Series: | Zdravniški Vestnik |
Subjects: | |
Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/2146 |
_version_ | 1828199253271379968 |
---|---|
author | Mojca Globočnik-Petrovič Andrejka Preskar |
author_facet | Mojca Globočnik-Petrovič Andrejka Preskar |
author_sort | Mojca Globočnik-Petrovič |
collection | DOAJ |
description | <p><strong>Background:</strong> Proliferative vitreoretinopathy (PVR) is a disease characterized by formation of membranes on both surfaces of the retina and vitreous base. PVR is a wound healing response which is inadequate and uncontrolled in the eye. Identifying the risk factors is important for PVR prediction. The distinction between anterior and posterior PVR is essential in predicting the surgery success.</p><p><strong>Conclusions:</strong> The anatomic and first of all functional success after vitrectomy are relatively poor. To improve the outcome the research has been focused on the use of pharmacological agents to prevent the development of PVR. A combination of 5-fluorouracil and low molecular weight heparin is the only proven effective therapy for PVR prevention.</p> |
first_indexed | 2024-04-12T10:52:19Z |
format | Article |
id | doaj.art-b0d24910e45243aab37d66093853cadd |
institution | Directory Open Access Journal |
issn | 1318-0347 1581-0224 |
language | English |
last_indexed | 2024-04-12T10:52:19Z |
publishDate | 2005-10-01 |
publisher | Slovenian Medical Association |
record_format | Article |
series | Zdravniški Vestnik |
spelling | doaj.art-b0d24910e45243aab37d66093853cadd2022-12-22T03:36:11ZengSlovenian Medical AssociationZdravniški Vestnik1318-03471581-02242005-10-0174101640Proliferative vitreoretinopathyMojca Globočnik-PetrovičAndrejka Preskar<p><strong>Background:</strong> Proliferative vitreoretinopathy (PVR) is a disease characterized by formation of membranes on both surfaces of the retina and vitreous base. PVR is a wound healing response which is inadequate and uncontrolled in the eye. Identifying the risk factors is important for PVR prediction. The distinction between anterior and posterior PVR is essential in predicting the surgery success.</p><p><strong>Conclusions:</strong> The anatomic and first of all functional success after vitrectomy are relatively poor. To improve the outcome the research has been focused on the use of pharmacological agents to prevent the development of PVR. A combination of 5-fluorouracil and low molecular weight heparin is the only proven effective therapy for PVR prevention.</p>http://vestnik.szd.si/index.php/ZdravVest/article/view/2146proliferative vitreoretinopathyclassificationrisk factorspharmacological therapypars plana vitrectomy |
spellingShingle | Mojca Globočnik-Petrovič Andrejka Preskar Proliferative vitreoretinopathy Zdravniški Vestnik proliferative vitreoretinopathy classification risk factors pharmacological therapy pars plana vitrectomy |
title | Proliferative vitreoretinopathy |
title_full | Proliferative vitreoretinopathy |
title_fullStr | Proliferative vitreoretinopathy |
title_full_unstemmed | Proliferative vitreoretinopathy |
title_short | Proliferative vitreoretinopathy |
title_sort | proliferative vitreoretinopathy |
topic | proliferative vitreoretinopathy classification risk factors pharmacological therapy pars plana vitrectomy |
url | http://vestnik.szd.si/index.php/ZdravVest/article/view/2146 |
work_keys_str_mv | AT mojcaglobocnikpetrovic proliferativevitreoretinopathy AT andrejkapreskar proliferativevitreoretinopathy |